COMMENTBiologic sales forecast to pass innovative small molecule sales in next five yearsThe telemedicine community has rallied to provide support to patients in UkraineOsteoarthritis pipeline shifting from analgesics to disease-modifying treatmentsSupply ChainCMO agreements need to go public, but ‘glib’ onshoring not the answerA new report commissioned by the US Congress recommends that the FDA should make drug supply chain information public. Fiona Barry writes about the potential implications.insightEurope reports the highest prevalence of chronic coughcommentCould vaccine hesitancy impact hearing disorders?Biologic sales forecast to pass innovative small molecule sales in next five yearsThe telemedicine community has rallied to provide support to patients in UkraineOsteoarthritis pipeline shifting from analgesics to disease-modifying treatments02/23/2024 23:27:10
Biologic sales forecast to pass innovative small molecule sales in next five years
The telemedicine community has rallied to provide support to patients in Ukraine
Osteoarthritis pipeline shifting from analgesics to disease-modifying treatments